Artificial intelligence in clinical research of cancers

Author:

Shao Dan1ORCID,Dai Yinfei1,Li Nianfeng1,Cao Xuqing2,Zhao Wei3,Cheng Li4,Rong Zhuqing5,Huang Lan6,Wang Yan6ORCID,Zhao Jing7

Affiliation:

1. College of Computer Science and Technology, Key Laboratory of Human Health Status Identification and Function Enhancement of Jilin Province, Changchun University, Changchun 130022, China

2. Department of Neurology, People’s Hospital of Ningxia Hui Autonomous Region (The Affiliated people’s Hospital of Ningxia Medical University and The First Affiliated Hospital of Northwest Minzu University), Yinchuan 750002, China

3. Department of Biochemistry and Molecular Biology, Ningxia Medical University, Yinchuan 750002, China

4. Department of Electrical Diagnosis, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, 130021, China

5. School of Science, Key Laboratory of Human Health Status Identification and Function Enhancement of Jilin Province, Changchun University, Changchun 130022, China

6. Key laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun 130012, China

7. Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, 43210, USA

Abstract

Abstract Several factors, including advances in computational algorithms, the availability of high-performance computing hardware, and the assembly of large community-based databases, have led to the extensive application of Artificial Intelligence (AI) in the biomedical domain for nearly 20 years. AI algorithms have attained expert-level performance in cancer research. However, only a few AI-based applications have been approved for use in the real world. Whether AI will eventually be capable of replacing medical experts has been a hot topic. In this article, we first summarize the cancer research status using AI in the past two decades, including the consensus on the procedure of AI based on an ideal paradigm and current efforts of the expertise and domain knowledge. Next, the available data of AI process in the biomedical domain are surveyed. Then, we review the methods and applications of AI in cancer clinical research categorized by the data types including radiographic imaging, cancer genome, medical records, drug information and biomedical literatures. At last, we discuss challenges in moving AI from theoretical research to real-world cancer research applications and the perspectives toward the future realization of AI participating cancer treatment.

Funder

National Natural Science Foundation of China

Development Project of Jilin Province of China

Guangdong Key Project for Applied Fundamental Research

Jilin Province Key Laboratory of Big Data Intelligent Computing

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

Reference109 articles.

1. Rise of the machines: advances in deep learning for cancer diagnosis;Levine;Trends Cancer,2019

2. Applications of machine learning in drug discovery and development;Vamathevan;Nat Rev Drug Discov,2019

3. When will AI exceed human performance? Evidence from AI experts;Grace;J Artif Intell Res,2018

4. Ensemble machine learning on gene expression data for cancer classification;Tan;Appl Bioinformatics,2003

5. Imagenet classification with deep convolutional neural networks;Krizhevsky;Adv Neural Inform Process Syst,2012

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3